2023
Work difficulties, work restrictions, and disability benefits in people with functional seizures: A survey study
Woodward J, Asadi-Pooya A, Mildon B, Tolchin B. Work difficulties, work restrictions, and disability benefits in people with functional seizures: A survey study. Epilepsy & Behavior Reports 2023, 23: 100610. PMID: 37645697, PMCID: PMC10460675, DOI: 10.1016/j.ebr.2023.100610.Peer-Reviewed Original ResearchFunctional seizuresWork restrictionsSignificant long-term disabilityOlder ageDisability benefitsLogistic regressionLong-term disabilityWork difficultiesPredictors of unemploymentExperienced disabilityDisability limitationsSeizuresPotential predictorsWork limitationsDemographic informationCurrent employment statusWork accommodationsDisabilityMajority of peopleCliniciansMost respondentsEmployment statusHigh percentageAgePredictors
2022
Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent
Chiong W, Tolchin BD, Bonnie RJ, Busl K, Cruz-Flores S, Epstein LG, Greene EP, Illes J, Kirschen M, Larriviere DG, Mantri S, Rubin MA, Stern BJ, Taylor LP. Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent. Neurology 2022, 98: 154-159. PMID: 34789544, DOI: 10.1212/wnl.0000000000013053.Peer-Reviewed Original Research
2021
How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers?
Tolchin B, Tolchin DW, Stein MA. How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? The AMA Journal Of Ethic 2021, 23: e530-536. PMID: 34351262, DOI: 10.1001/amajethics.2021.530.Peer-Reviewed Original Research